Cost-utility Analysis of Dornase alfa in comparison with Tobramycin for Managing Iranian Patients with Cystic Fibrosis.
Autor: | Heydari, Fatemeh Sadat1 heydari.f96@gmail.com |
---|---|
Zdroj: | Journal of Pharmacoeconomics & Pharmaceutical Management. Winter2023, Vol. 9 Issue 1, p39-48. 10p. |
Databáze: | Business Source Ultimate |
Externí odkaz: |